logo

MREO

Mereo Biopharma·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
4.23 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Is MREO a Good Buy Right Now?
  • Based on a composite score of 4.23/10, we rate MREO as a Netural. Our analysis breaks down into 2.69/10 for Fundamentals, 4.68/10 for Technicals, and 4.78/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is MREO undervalued or overvalued?
Technical Analysis of MREO?
What is the analyst consensus for MREO?